Key medical figures:
• 2,200 patients under treatment for TB, of which 516 for MDR-TB
• 200 patients on first-line ARV treatment
A pilot project to shorten treatment time for people with multidrug-resistant tuberculosis (MDR-TB)was launched in 2013.
In September, a three-year project aimed at improving access to reproductive health services in Luwingu district came to an end. Uzbekistan is one of many countries in
Central Asia with high levels of drugresistant TB (DR-TB), a form of the disease that does not respond to the standard first-line drug regimen. Access to proper diagnosis and care is still limited and the vast majority of people with DR-TB remain undiagnosed and untreated.
In the Autonomous Republic of Karakalpakstan, Médecins Sans Frontières (MSF) has been running a TB programme in collaboration with the Ministry of Health since 1997. In 2013, 1,212 patients were enrolled for first-line TB treatment, as well as 677 for DR-TB. Many patients underwent treatment on an outpatient basis, so they avoided the additional stress of hospitalisation and could remain at home close to their families and social support network. Overall, nearly two-thirds of the DR-TB patients began ambulatory care. In September 2013,
16 MDR-TB patients were enrolled in a pilot project in which the often arduous treatment that usually takes up to two years was shortened to nine months.
The DR-TB project expanded this year into the districts of Chimbay, Shumanay and Kanlikul, while activities in the districts of Khodjeily, Takhiatash and Nukus region were handed over to local health authorities. In Tashkent, Uzbekistan’s capital city, an MSF team continued to work at the Republican AIDS Centre, and activities began at the Tashkent City AIDS Centre in September. Psychosocial activities such as counselling were also provided as an additional support for people living with HIV.
No. staff end 2013: 184 | Year MSF first worked in the country: 1997